Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV vaccine - Janssen

Next Previous
Search
Drug Profile

HIV vaccine - Janssen

Alternative Names: HIV virus vaccine - Bavarian Nordic; Human human immunodeficiency virus vaccine - Bavarian Nordic; Modified Vaccinia Ankara Bavarian Nordic HIV vaccine; MVA-BN HIV; MVA-BN HIV vaccine - Bavarian Nordic

Latest Information Update: 24 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bavarian Nordic
  • Developer Janssen
  • Class AIDS vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 24 Nov 2021 Discontinued - Preclinical for HIV-1 infections in USA (Parenteral) (Bavarian Nordic pipeline, November 2021)
  • 28 Oct 2021 No recent reports of development identified for preclinical development in HIV-1-infections in USA (Parenteral)
  • 30 Jul 2021 Beth Israel Deaconess Medical Centre plans a phase I/II trial for HIV infection (In adults, In elderly, Combination therapy) in USA (NCT04983030)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top